Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Oral Boards J > NMBs > Flashcards

NMBs Flashcards

1
Q

Rocuronium Class

A

Steroidal nondepolarizing muscle blocking agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rocuronium Clinical Use

A

Standard and rapid sequence induction, reduce damage to vocal cords

maintenance of neuromuscular blockade

Improve surgical working conditions, immobility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Rocuronium MOA

A

Competitively blocks nicotinic receptors in the NMJ preventing ACh from binding → channel remains closed and post synaptic membrane remains polarized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rocuronium Dose

A

Induction dosing: 0.6 – 1.2 mg/kg

RSI dose: 1.2 mg/kg

Maintenance 1/5th

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rocuronium Pharmacokinetics

A

Onset = 1 - 3 min

DOA = 30 - 60 min

Metabolism = hepatic and renal

Excretion = Liver 20% and kidney 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rocuronium Contraindications

A

hypersensitivity - Neuromuscular blocking agents and antibiotics are the most common drugs involved in intraoperative allergic reactions

Depend on hepatic and renal elimination, caution in patients with impaired function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rocuronium Considerations

A
  • No hypnosis or analgesia
  • Quaternary ammonium does NOT cross BBB
  • sedated prior to admin and adequate ventilation
  • Reverse with sugammadex
  • Hepatic and renal system
    • The steroidal relaxants rocuronium & vecuronium depend to varying degrees on renal and hepatic elimination
  • Hypothermia prolongs duration of action.
  • Drug interactions:
  • Prolonged by:
    • Volatiles
    • Hypothermia
    • Magnesium
    • Lithium
    • IV local anesthetic
  • Shortened by:
  • Long term anti-epileptics, resistant to NMB
  • Steroids antagonize NMB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Vecuronium Class

A

Steroidal nondepolarizing muscle blocking agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Vecuronium Use

A
  • Standard induction and maintenance of neuromuscular blockade
  • Improve surgical working conditions, immobility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vecuronium MOA

A

Competitively blocks nicotinic receptors in the NMJ preventing ACh from binding → channel remains closed and post synaptic membrane remains polarized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Vecuronium Dose

A

Induction = 0.1 mg/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vecuronium Pharmacokinetics

A
  • Onset = 2 - 4 min
  • DOA = 30 - 60 min
  • Metabolism = hepatic and renal
  • Excretion = Liver 50% and kidney 50%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vecuronium Contraindications

A
  • hypersensitivity - Neuromuscular blocking agents and antibiotics are the most common drugs involved in intraoperative allergic reactions
  • Depend on hepatic and renal elimination, caution in patients with impaired function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vecuronium Considerations

A
  • No hypnosis or analgesia
  • Quaternary ammonium does NOT cross BBB
  • Must be reconstituted
  • Reverse with sugammadex
  • Hepatic and renal system
    • The steroidal relaxants rocuronium & vecuronium depend to varying degrees on renal and hepatic elimination
  • Hypothermia prolongs duration of action
  • Drug interactions:

Prolonged by:

  • Volatiles
  • Hypothermia
  • Magnesium
  • Lithium
  • IV local anesthetic
  • Shortened by:
  • Long term anti-epileptics, resistant to NMB
  • Steroids antagonize NMB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cisatracurium Class

A

Benzylisoquinolinium nondepolarizing muscle blocking agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cisatracurium Use

A
  • Standard induction and maintenance of neuromuscular blockade
  • Improve surgical working conditions, immobility
17
Q

Cisatracurium MOA

A

Competitively blocks nicotinic receptors in the NMJ preventing ACh from binding → channel remains closed and post synaptic membrane remains polarized

18
Q

Cisatracurium Dose

A

Induction 0.1 mg/kg

19
Q

Cisatracurium Pharmacokinetcs

A
  • Onset = 2 - 4 min
  • DOA = 30 - 60 min
  • Metabolism = Hoffman elimination (75%) and nonspecific esterase hydrolysis (25%)
    • Laudanosine metabolite (CNS stimulant)
  • Excretion = Kidney
20
Q

Cisatracurium Contraindications

A

hypersensitivity - Neuromuscular blocking agents and antibiotics are the most common drugs involved in intraoperative allergic reactions

21
Q

Cisatracurium Considerations

A
  • No hypnosis or analgesia
  • Quaternary ammonium does NOT cross BBB
  • Hofmann elimination is a temperature- and pH-dependent break- down of the drug molecule.
  • CANNOT! reverse with sugammadex
  • Best agent for patients with kidney or liver failure
  • Hypothermia prolongs duration of action
  • Drug interactions:

Prolonged by:

  • Volatiles
  • Hypothermia
  • Magnesium
  • Lithium
  • IV local anesthetic
  • Shortened by:
  • Long term anti-epileptics, resistant to NMB
  • Steroids antagonize NMB
22
Q

Succinylcholine Class

A

Depolarizing muscle blocking agent

23
Q

Succinylcholine Clinical Use

A

rapid sequence induction, laryngospasm, ECT

24
Q

Succinylcholine MOA

A

Attaches to one or both alpha subunits of the nicotinic acteylcholine receptors and mimics ACh, thus depolarizing the postjunctional membrane

25
Q

Succinylcholine Dose

A
  • Induction dosing: 1 – 1.5 mg/kg
  • IM induction: 4 mg/kg
  • Laryngospasm: 20 - 40 mg
26
Q

Succinylcholine Pharmacokinetics

A
  • Onset = 30 - 60 sec
  • DOA 5 - 15 min
  • Metabolism = plasma cholinesterases (pseudocholinesterases/butyrocholinesterase) which are made in the liver. Prolonged metabolism with plasma cholinesterase deficiency
  • Excretion = kidneys
27
Q

Succinylcholine Contraindications

A
  • HyperKalemia
  • Burn patients with injuries of over 35% total Body surface area (TBSA),third-degree burn
  • Severe muscle trauma
  • Neurologic injury (e.g., paraplegia, quadriplegia)
  • Severe sepsis (e.g., abdominal)
  • Muscle wasting, prolonged immobilization, extensive muscle denervation
  • Malignant hyperthermia or family history
  • Duchenne muscular dystrophy
  • Children <8 yo (Should only be used in children under 8 years old only in emergency situations; not for routine intubation)
  • Genetic variants of pseudocholinesterase defect (dibucaine test, 80% inhibition is normal)
  • Allergy
28
Q

Succinylcholine Considerations

A
  • Bradycardia due to direct stimulation of muscarinic receptors of the SA node
    • F/U w/ atropine
  • Risk of hyperkalemia, worse with burn/trauma/head injury patients
  • Increases ICP, IOP and gastric pressures
  • Fasciculations and post op muscle pain can occur
  • Rhadbomyolysis can lead to hyperkalemia and cardiac arrest
  • Quaternary ammonium does NOT cross BBB

Oral Boards J (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions